Shannon Lantzy MedCrypt New VP of Consulting

Lantzy Will Leverage Her Regulatory Science & Business Transformation Experience fron Working with Booz Allen Hamilton, the FDA, & NASA to Launch MedCrypt's Consulting Services

MedCrypt the proactive cybersecurity solution provider for medical devices, today announced the addition of Shannon Lantzy, Ph.D., as their new Vice President of Consulting.

Prior to joining MedCrypt, Shannon Lantzy spent six years with Booz Allen Hamilton where she led the Regulatory Science Innovation team, partnering with the U.S. Food and Drug Administration (FDA) to develop, test, and evaluate new approaches to regulatory decisions and benefit-risk assessments.

Shannon Lantzy also co-founded Booz Allen’s Secure Connected Health practice and brought together a diverse set of experts, cybersecurity tools, and strategies to solve cybersecurity challenges relating to patient safety. Before Booz Allen, Lantzy was a consultant for NASA, helping with organizational strategy, capability assessment, enterprise architecture, technology adoption, and process improvement. Lantzy earned a Ph.D. in Information Systems from Robert H. Smith School of Business at the University of Maryland.

“Advancements in connected technology have paved the way for a future of healthcare that is digital and delivered in new environments,” said Shannon Lantzy, MedCrypt Vice President of Consulting. “To build this digital landscape and to support future innovation, healthcare needs a baseline of secure infrastructure. The MedCrypt team is working with some of the world’s largest medical device manufacturers to improve their medical device security posture and I am both eager and proud to join in on their efforts.”

At MedCrypt, Shannon Lantzy will be responsible for leading MedCrypt’s Consulting Services to bring clinically innovative medical devices that are secure by design through their lifecycle. She will lead and support consulting engagements, ensuring MedCrypt’s customers meet their business outcomes and the pre-and post-market cybersecurity guidelines from the FDA.

“I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future,” said Mike Kijewski, CEO of MedCrypt. “We’re excited to have Shannon join our team to help our customers transform from reactive to proactive product security.”

Other Executives In the News

SourceMedCrypt
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.
Chistine Senn will serve as Chair of the Site-Sponsor Consortium – a collaborative body now in its second year – and as Chair of Advarra's Customer Advisory Board. She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra's mission.
Christopher Slachta joins Cytovale after serving 12 years at Abbott, most recently as divisional vice president of global operations and supply chain, molecular diagnostics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy